Omicron Sensing Pvt Ltd company information, Employees & Contact Information

The Omicron variant is highly resistant against antibody-mediated neutralization: Implications for control of the COVID-19 pandemic ScienceDirect.com

Protection against the Omicron Variant from Previous SARS-CoV-2 Infection The New England Journal of Medicine

Omicron: A Heavily Mutated SARS-CoV-2 Variant Exhibits Stronger Binding to ACE2 and Potently Escapes Approved COVID-19 Therapeutic Antibodies Frontiers

Considerable escape of SARS-CoV-2 Omicron to antibody neutralization Nature

Divergent SARS-CoV-2 Omicron–reactive T and B cell responses in COVID-19 vaccine recipients Science | AAAS

Omicron, Delta, Alpha, and More: What To Know About the Coronavirus Variants Yale Medicine

Omicron mutations enhance infectivity and reduce antibody neutralization of SARS-CoV-2 virus-like particles PNAS

Update on Omicron World Health Organization (WHO)

SARS-CoV-2 Omicron Variant Neutralization in Serum from Vaccinated and Convalescent Persons The New England Journal of Medicine

Structural and functional characterizations of infectivity and immune evasion of SARS-CoV-2 Omicron ScienceDirect.com

Striking antibody evasion manifested by the Omicron variant of SARS-CoV-2 Nature

Third BNT162b2 Vaccination Neutralization of SARS-CoV-2 Omicron Infection The New England Journal of Medicine

SARS-CoV-2 Omicron is an immune escape variant with an altered cell entry pathway Nature

Effectiveness of BNT162b2 Vaccine against Omicron Variant in South Africa The New England Journal of Medicine

SARS-CoV-2 Omicron variant: recent progress and future perspectives | Signal Transduction and Targeted Therapy Nature

Effect of mRNA Vaccine Boosters against SARS-CoV-2 Omicron Infection in Qatar The New England Journal of Medicine

Effectiveness of mRNA-1273 against SARS-CoV-2 Omicron and Delta variants Nature

BNT162b2 Protection against the Omicron Variant in Children and Adolescents The New England Journal of Medicine

Effectiveness and Durability of the BNT162b2 Vaccine against Omicron Sublineages in South Africa The New England Journal of Medicine

Postacute Sequelae of SARS-CoV-2 Infection in the Pre-Delta, Delta, and Omicron Eras The New England Journal of Medicine

Imprinted SARS-CoV-2 humoral immunity induces convergent Omicron RBD evolution Nature

Omicron escapes the majority of existing SARS-CoV-2 neutralizing antibodies Nature

From Alpha to Omicron: Everything you need to know about SARS-CoV-2 variants of concern Gavi, the Vaccine Alliance

Omicron and its Subvariants: A Guide to What We Know Yale Medicine

Covid-19 Vaccine Effectiveness against the Omicron (B.1.1.529) Variant The New England Journal of Medicine

SARS-CoV-2 Omicron variant replication in human bronchus and lung ex vivo Nature

Emergence of SARS-CoV-2 Omicron lineages BA.4 and BA.5 in South Africa Nature

Population Immunity and Covid-19 Severity with Omicron Variant in South Africa The New England Journal of Medicine

Neutralization Escape by SARS-CoV-2 Omicron Subvariant BA.4.6 The New England Journal of Medicine

SARS-CoV-2 B.1.1.529 (Omicron) Variant — United States, December 1–8, 2021 Centers for Disease Control and Prevention | CDC (.gov)

SARS-CoV-2 Omicron Variant Neutralization after mRNA-1273 Booster Vaccination The New England Journal of Medicine

Neutralization Escape by SARS-CoV-2 Omicron Subvariants BA.2.12.1, BA.4, and BA.5 The New England Journal of Medicine

Effects of Previous Infection and Vaccination on Symptomatic Omicron Infections The New England Journal of Medicine

Duration of mRNA vaccine protection against SARS-CoV-2 Omicron BA.1 and BA.2 subvariants in Qatar Nature

Effects of Vaccination and Previous Infection on Omicron Infections in Children The New England Journal of Medicine

Broadly neutralizing antibodies overcome SARS-CoV-2 Omicron antigenic shift Nature

Substantial Neutralization Escape by SARS-CoV-2 Omicron Variants BQ.1.1 and XBB.1 The New England Journal of Medicine

SARS-CoV-2 Omicron virus causes attenuated disease in mice and hamsters Nature

BA.2.12.1, BA.4 and BA.5 escape antibodies elicited by Omicron infection Nature

Antibody Response to Omicron BA.4–BA.5 Bivalent Booster The New England Journal of Medicine

Attenuated replication and pathogenicity of SARS-CoV-2 B.1.1.529 Omicron Nature

Efficacy of a Fourth Dose of Covid-19 mRNA Vaccine against Omicron The New England Journal of Medicine

Duration of Shedding of Culturable Virus in SARS-CoV-2 Omicron (BA.1) Infection The New England Journal of Medicine

Report on Omicron Spike mutations on epitopes and immunological/epidemiological/kinetics effects from literature Virological

In Vitro Efficacy of Antiviral Agents against Omicron Subvariant BA.4.6 The New England Journal of Medicine

Virological characteristics of the SARS-CoV-2 XBB variant derived from recombination of two Omicron subvariants Nature

Omicron booster shots are coming—with lots of questions Science | AAAS

A Bivalent Omicron-Containing Booster Vaccine against Covid-19 The New England Journal of Medicine

Durability of XBB.1.5 Vaccines against Omicron Subvariants The New England Journal of Medicine

Anti-Spike Mucosal IgA Protection against SARS-CoV-2 Omicron Infection The New England Journal of Medicine

SARS-CoV-2 Omicron variant: Antibody evasion and cryo-EM structure of spike protein–ACE2 complex Science | AAAS

Effectiveness of Bivalent Boosters against Severe Omicron Infection The New England Journal of Medicine

SARS-CoV-2 evolution, post-Omicron Virological

Genomic assessment of invasion dynamics of SARS-CoV-2 Omicron BA.1 Science | AAAS

Evolution of enhanced innate immune suppression by SARS-CoV-2 Omicron subvariants Nature

Protection by a Fourth Dose of BNT162b2 against Omicron in Israel The New England Journal of Medicine

What does Omicron mean for future COVID-19 vaccinations? Science | AAAS

The Omicron Booster: Your Questions Answered Yale Medicine

Co-infection with SARS-CoV-2 Omicron and Delta variants revealed by genomic surveillance Nature

Where did ‘weird’ Omicron come from? Science | AAAS

Convergent evolution of SARS-CoV-2 Omicron subvariants leading to the emergence of BQ.1.1 variant Nature

Effectiveness of BNT162b2 Vaccine against Omicron in Children 5 to 11 Years of Age The New England Journal of Medicine

Nirmatrelvir Use and Severe Covid-19 Outcomes during the Omicron Surge The New England Journal of Medicine

Efficacy of Antibodies and Antiviral Drugs against Covid-19 Omicron Variant The New England Journal of Medicine

Early Data on Omicron FactCheck.org

Rapid epidemic expansion of the SARS-CoV-2 Omicron variant in southern Africa Nature

Efficacy of Antiviral Agents against Omicron Subvariants BQ.1.1 and XBB The New England Journal of Medicine

Efficacy of Antibodies and Antiviral Drugs against Omicron BA.2.12.1, BA.4, and BA.5 Subvariants The New England Journal of Medicine

Molecular basis of receptor binding and antibody neutralization of Omicron Nature

Altered host protease determinants for SARS-CoV-2 Omicron Science | AAAS

Tracking SARS-CoV-2 variants World Health Organization (WHO)

Efficacy of Antiviral Agents against the SARS-CoV-2 Omicron Subvariant BA.2 The New England Journal of Medicine

Q&A on the Omicron Variant FactCheck.org

A vaccine only for Omicron: Does India really need it? Down To Earth

What is Omisure, India’s first RT-PCR kit that identifies omicron in under 4 hours Down To Earth